The current study aimed at prospectively assessing the performance of IUC as a predictive tool for residual tumor after primary TURBT of NMIBC, and possible future recurrence.
The current study aimed at prospectively assessing the performance of IUC as a predictive tool for residual tumor after primary TURBT of NMIBC, and possible future recurrence.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
198
Forty-eight hours after primary TURBT, IUC was retrieved and patients were scheduled for repeat TURBT 2 to 6 weeks later according to the predetermined protocol. The primary outcome was to determine the role of positive IUC to predict positive biopsy findings on repeat TURBT.
Diagnostic performance of IUC
The primary outcome included assessment of the performance of IUC as a predictive tool for possible residual malignancy after primary TURBT. Thereafter, sensitivity (Sn), specificity (Sp), positive and negative predictive values (PPV, NPV) and overall accuracy of IUC as a preliminary step before repeat TURBT will be determined.
Time frame: It was assessed 48 hours after primary TURBT
The secondary outcome included the evaluation of predictive capacity of IUC for tumor recurrence in the study participants.
The secondary outcome included the evaluation of predictive capacity of IUC for tumor recurrence in the study participants.
Time frame: Within duration of follow up (4 years )
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.